
|Articles|November 26, 2012
FDA approves first cell-culture vaccine for seasonal influenza
FDA approved Influenza Virus Vaccine (Flucelvax, Novartis Vaccines), the first cell-culture-derived vaccine, for individuals aged 18 years of age and older.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Navigating Compounding Peptides and GLP-1s Through Regulations
2
Overcoming the Structural Squeeze Through Policy and Coordination
3
Pharmacist Involvement Speeds Prior Authorization for GLP-1s
4
The 2026 GLP-1 Compounding Crackdown: A Pharmacist’s Guide
5


























